Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti–PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells
Benjamin Boyerinas(University of Chicago), Jeffrey Schlom(National Cancer Institute), Caroline Jochéms(National Cancer Institute), Kwong Y. Tsang(Center for Biologics Evaluation and Research), Christopher R. Heery(National Cancer Institute), James L. Gulley(National Cancer Institute), Massimo Fantini(National Cancer Institute)
Cited by 456
Related Papers
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
|The Journal of Experimental Medicine|2006|1.7k
Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
|Journal of Clinical Oncology|2010|973
Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide
|Blood|2005|896
The role of let-7 in cell differentiation and cancer
|Endocrine Related Cancer|2009|669